Susanna Carolina Berger

Susanna Carolina Berger serves as a Working Group Leader at the Interdisciplinary Clinic and Polyclinic for Stem Cell Transplantation at the University Medical Center Hamburg-Eppendorf. With an extensive publication record spanning over two decades, Dr. Berger is a prominent researcher in the field of cellular immunotherapy and stem cell transplantation.

Dr. Berger's research primarily focuses on CAR-T cell therapy applications in hematological malignancies, stem cell transplantation outcomes, and molecular monitoring of cellular therapies. Her work has significantly contributed to understanding neurotoxicity in CAR-T cell therapy, developing monitoring techniques for CAR-T cell expansion, and improving treatment strategies for multiple myeloma and lymphoma. She has published extensively on CD19-targeted therapies, molecular monitoring techniques including digital PCR, and the management of complications associated with cellular immunotherapies.

Analysis of her 15 most recent publications reveals a strong emphasis on translational research, with particular focus on real-world applications of CAR-T cell therapy, molecular monitoring techniques, and the management of treatment-related toxicities. Her work bridges laboratory research with clinical applications, addressing critical challenges in cellular immunotherapy including neurotoxicity, hematological toxicity, and treatment response monitoring.

Dr. Berger actively collaborates with leading researchers in the field, including Kröger, Fehse, Ayuk, and Riddell, and participates in major European research networks focused on cellular therapies. Her work has been presented at significant conferences including the EBMT Annual Meeting and the European CAR T-Cell Meeting, demonstrating her active engagement in the international research community.